chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Screamed for 5 hrs; t103 x 2 days; area on rt was red & swollen;
Product temperature excursion issue; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Nov-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue). On 02-Nov-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant Drug details were reported.  No Treatment information was provided
COVID Arm Itchy, swollen, and red at injection on 4/24. Now red rash half moon under injection spot
Hives starting 11 days after vaccination, starting on forearms and right elbow, extending subsequent day to neck, groin and armpits, extending subsequent day to knees and torso, extending subsequent day to feet, hands, and behind ears into hairline, still continuing.  Earliest sites seem to dissipate after ~3 days , but some bruising remains in groin area. Rash is itchy, hot and painful, but no fever.  It should be noted that patient had "Covid Arm" (swollen inflamed at injection site) ~14 days after 1st vaccination lasting 3 days, and suffered chills after 2nd shot same day,  lasting 1 day.
pt recv vax 28MAR96 & 29JUN97 pt devel a maculopapular rash all over;exp pruritus & fever that same day;it was noted that pt was exposed to varicella 3wk prior to onset of events;pt recovered;
Thirty four hours after my vaccine all of a sudden it felt as though someone gave me a tranquilizer. Everything started spinning, I felt nauseous and could not keep conscience. I felt paralized. I could not lift any part of my body. I passed out! I remember this morning that I could faintly hear my husband on the phone trying to get help. I feel much better today, but still dizzy and nauseous, but nothing like what hit me last night. It was as if someone had given me anesthesia. I could not find anyone on line that had this reaction?
Patient reported feeling dizzy and tingly all over her body. Patient's face was visibly red and stated her lips were numb
Information has been received from a registered nurse (R.N) concerning an approximately 36 months old (reported as "at 3 age") patient who on an unspecified date received unknown varicella vaccination at age one. The patient developed mild chickenpox at age 3. The caller was unsure if the first vaccination was with VARIVAX (Merck) brand or another. At the time of reporting, the patient's outcome was unknown. It was unspecified if the patient sought medical attention. Additional information has been requested.
Shortness of Breath when doing aerobic exercises.   Chest tenderness around heart.   Going to ER on 5/23.
Dose 1: 17Mar2021 / Dose:2 07May2021; light headedness/dizziness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 07May2021 11:45 (Lot number: ER8737) at the age of 65 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "DVT left leg", start date: 2006 (unspecified if ongoing), notes: Other medical history: DVT left leg 2006; "Fibroids/recom surgery uterus" (unspecified if ongoing), notes: Uterine fibroids removal reconstruction. There were no concomitant medications. Past drug history included: Naproxen, reaction(s): "Known allergies", notes: Known allergies: Naproxen. Vaccination history included: Bnt162b2 (Dose number: 1, Prev dose lot number= EN6204, Prev dose lot unknown=false, Prev dose administration date=17Mar2021, Prev dose administration time=10:30 AM, Prev dose dose number=1, Prev dose vaccine location=Right arm), administration date: 17Mar2021, when the patient was 65 years old, for COVID-19 immunization. The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 07May2021 11:30, described as "Dose 1: 17Mar2021 / Dose:2 07May2021"; DIZZINESS (non-serious) with onset 07May2021 11:30, described as "light headedness/dizziness". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient was not pregnant at the time of vaccination. Other vaccine in four weeks was reported as no. Other medications in two weeks were reported as none.  Follow-up attempts are completed. No further information is expected.
12-15-2008 Hospitalized for fever- max 103.3, rectal, diarrhea with some blood in the  stool. Stool culture grew out Salmonella. Patient was then treated with bactrim and recovered. 12/31/08-records received  for DOS 12/15-12/16/08-DC DX: Fever and Salmonella gastroenteritis. Presented to ED with 3 day history of fever, cough and hematochezia which developed morning of admission. Fussy. Blood in stool.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and PARACETAMOL (TYLENOL) for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN (pain). At the time of the report, PAIN (pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
SWELLING AND REDNESS OVER ENTIRE DELTOID, TENDERNESS, FLU LIKE SYMPTOMS, FEVER.
Fever, NauseaVomiting, Fever, Aches, Chills, Vomiting, Fatigue x 3 days Narrative:  Other Relevant History:
hives around inject site, general aches, nausea; 31AUG92 f/u 14 days followng booster pt resented w/generalized urticaria, joint aching & periorbital edema; pt referred to MD;
Burning Red Area when shower water touches the red area; Rash on the Right Arm (3") and Back; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on the Right Arm (3") and Back) and ERYTHEMA (Burning Red Area when shower water touches the red area) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for Covid-19 Vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced RASH (Rash on the Right Arm (3") and Back) and ERYTHEMA (Burning Red Area when shower water touches the red area). At the time of the report, RASH (Rash on the Right Arm (3") and Back) and ERYTHEMA (Burning Red Area when shower water touches the red area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   ? No treatment information was provided.
Right arm red 2 1/4 x 3 1/2, slight swelling, warm to touch, during injection notation made of patient moved around.
had shingles recently; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: (159558). The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), in 2021 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series complete,, Unknown manufacturer), for COVID-19 Immunization. The following information was reported: HERPES ZOSTER (non-serious), outcome "unknown", described as "had shingles recently". Therapeutic measures were taken as a result of herpes zoster. Additional information; Call transferred by withheld from Covax support CEP 159558. The patient is a consumer (refused to give phone number or address) who is asking about when he can get the Pfizer COVID 19 2nd booster vaccine. The patient stated he had his 1st Pfizer COVID 19 booster vaccine 6 months ago patient stated that his doctor thought he may have had shingles recently and had him taking an antiviral. The patient stated his doctor told him to wait 2 weeks until getting his 2nd Pfizer Covid19 booster vaccine since he recently had shingles. The patient is asking "do I need to wait 2 weeks before having my 2nd booster vaccine". Response: Confirmed Pfizer Covid19 2nd booster vaccine. Resolution: Swap Survey: First Connect to Covax US Support. Read privacy statement and Gather info, The patient refused to provide his address and phone number. Read. Provided PMI's HOO and phone number. Warm transferred (withheld).  Provided: COVAX US Support and CEP159558. Created Manual AE Form  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recvd vax; pt exp headache, dizziness, upset stomach, & diarrhea;
Bilateral retinal branch vein occlusions 1 month after. Died 5/7/21
Patient was feeling dizzy and under the weather after the vaccination. The following day he died in his sleep during a nap.
(L) shoulder pain after receiving the flu shot, no swelling or redness but pt complained of significant pain when palpated. He couldn't lift his arm in line w/ his shoulder; was referred to ortho walk-in.
Approximately 5 hours after receiving vaccine, pt started experiencing red splotches on chest and neck and felt feverish. No swelling of throat or tongue, and no trouble breathing.
her arm was painful for a week then she asked her doctor who told her a nerve damge may happened too
terrible flu; Initial information was received on 24-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-health-care professional.  This case involves unknown age female patient who had terrible flu after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (form, strength, dose, frequency, lot number, expiry date: unknown) via unknown route in unknown administration site for Prophylactic vaccination  On an unknown date the patient developed terrible flu (influenza) (unknown latency) following the administration of influenza vaccine.  It is unknown if there were lab data/results available.  Reportedly, A friend of mine got it and she's had terrible flu since... for about a month now. Someone I used to work with died right after she got it. She was in her 40s and had young kids.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (terrible flu).  At time of reporting, the outcome was Unknown for the event terrible flu.
210PM mom called & stated pt was difficult to awake; pt woke up from nap crying & then kept falling asleep; mom stated pt was pale in color & rolled eyes back; This occurred for less than 2 mins; Pt taken outside for air; VS stable; no temp
vertigo; nausea; vomiting; leg pain; numbness after the first dose of the vaccine; ataxic; off work; This is a spontaneous report from a contactable consumer via Pfizer sales representative. This consumer reported for a 45-year-old female patient that:  A 45-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EK5730), via an unspecified route of administration on 19Jan2021 as SINGLE DOSE for covid-19 immunization.  The patient medical history and concomitant medications were not reported. The patient experienced vertigo, nausea, vomiting, leg pain, numbness after the first dose of the vaccine, ataxic, off work on an unspecified date. Caller stated those symptoms went away then came back after the second dose. Patient could not walk from the leg pain for a period of time. Event took place after use of product. Caller stated patient had similar but less severe symptoms. Caller stated had reported those cases already, and in the process of inquiring more information about your question. Caller stated all 3 of these cases we discussed received their Pfizer through 2 hospitals vaccine in Jan and 2 received it within 48hrs of each other. This may be a batch issue. one Lot was FL3247 on 21Jan2021 given at (Hospital Initial). Caller stated can provide more Lot, further details, and contact info for the 3 cases. caller stated with the 2nd patient and lot number EK5730, date of that vaccine 19Jan was, subsequent one was EL1284, caller stated that patient was not improving had ataxic and off work. Medical without had been negative for causes other than the vaccine. Caller stated Since there were reports of polyneuropathy, need to know more about those cases. Ideally how they were treated, did it resolve, what did they learn from their workups regarding the mechanism for this reaction, etc. The outcome of events was unknown.   Follow up (13Mar2021): New information received in response to this follow up spontaneous report from a contactable consumer via Pfizer sales representative.  This consumer reported for a patient included: case narrative.  Follow up (16Mar2021): New information received in response to this follow up spontaneous report from a contactable consumer via Pfizer sales representative. This consumer reported for a patient included that: event information and case narrative.  No follow-up attempts are possible. No further information is expected.
Information has been received from a physician concerning a 71 year old female family member with no pertinent medical history who in approximately August 2007 was vaccinated with a dose of ZOSTAVAX (Oka/Merck).  Concomitant therapy included unspecified blood pressure medication, CLARITIN, and meclizine.  The physician reports that the female family member developed tooth pain about a month to a month and one half after the administration of the vaccine.  The family member went to a dentist and was told that the tooth pain was related to "herpetic lesions" in the mouth.  The family member was directed to use a topical antiviral (unspecified) by the dentist, but decided to take VALTREX.  The mouth lesions "cleared" with the VALTREX (duration of treatment and time to resolution unspecified).  The family member developed jaw and ear pain described as a shooting pain with vertigo some time after the oral herpetic lesions cleared  (time to development uncertain).  The family member went to the emergency room due to vertigo and ear pain in January 2008), then to a neurologist, an otolaryngologist, and a gastroenterologist over a 5 month period all with negative findings, but with continued pain, nausea and weight loss of 22 pounds.  The family member also developed "linear lesions" of unspecified duration or location since vaccination (The physician did not see the lesions).  Diagnostic studies performed included an MRI, CT scan of the head and abdomen, endoscopy, and unspecified blood tests.  The physician considered the adverse experiences to be disabling.  No product quality complaint was involved.  The physician in the case is not the physician who administered the ZOSTAVAX (Oka/Merck).  Additional information has been requested.
Received SHINGRIX on 7/24/18 at local pharmacy. Noted local pain at injection site briefly. Next morning 7/15/18 redness and tenderness of upper arm and developed whole body soreness. Following day 7/26/18 awakened with face swelling 'like a chipmunk and continued soreness of the left upper arm, but body pain much better. Symptom of facial swelling resolved within 2 hours after OTC ALLEGRA. On 7/27/2018 patient presented to office to report the event, and feels well. The left upper arm has redness, warmth, mild induration in patch 15 x 8 cm, and tenderness only at the injection site. Decision was made to report to VAERS.
sinus infection; nasal dripping; sinus infection; nasal dripping; This is a spontaneous report from a non-contactable consumer or other non hcp.A patient of unspecified age and gender received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization.The patient medical history and concomitant medications were not reported. On an unknown date, the patient experienced sinus infection and nasal dripping. It was reported that patient had the vaccine almost about 2 days ago and had the sinus infection, knew that had been getting one. Also asked that can patient take Nasonex. The patient did not had any side effects. Had nasal dripping, patient get this a lot nothing new. The outcome of events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient  received vaccine at 11:54. approximately 3 minutes after injection patient stated that it felt like her heart was racing. Heartrate 144, B/P 154/96, O2 SAT 99. patient was in a supine position at time of injection and at when vitals were taken. she also had complaints of being light headed and have a little bit of Nausea. Continued to monitor every 5 minutes. Heart rate started to improve @ 12:10, Heart rate 99, B/P 132/91, O2 sat 99. Patient discharged at 12 24 in stable condition B/P 142/96, HR 101. Patient instructed to follow up with her PCP due to an elevated BP/ she stated that she does not know what her base line BP is however she will make an appointment as soon as she gets home. .
Drug ineffective; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 22-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05May2021 as dose 2, single (Batch/Lot number: unknown) at the age of 21 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: It was reported that the patient was treated with Paxlovid from 18Jul2022 to 23Jul2022 for Covid-19. It was unknown if other medications the patient received within 2 weeks of vaccination.  Follow-up attempts are completed. No further information is expected.
This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a male patient who received TWINRIX (batch number AHABB251AA, expiry date 30th May 2014). On an unknown date, the patient received TWINRIX. On an unknown date, an unknown time after receiving TWINRIX, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional information: MD office reports that a patient was inadvertently administered an expired dose of TWINRIX.
Awoke on 1-19 at 5 am shaking from chills was very cold checked temperature was at 101 checked throughout the day  and rose as high as 102.8 had body aches and headache arm very sore dizzy and lightheaded  1-20 arm still sore and has a red patch size of palm at injection site and has become very itchy but too  sore to scratch fever at 100 at night fever rose to 101. 1-21 arm still sore and red and still very itchy no fever still feel a little out of it missed 2 days work but am back today
This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 63-year-old female patient who received SHINGRIX for prophylaxis. Concomitant products included Vitamins. On 10th May 2018, the patient received the 1st dose of SHINGRIX. On 11th May 2018, 1 days after receiving SHINGRIX, the patient experienced injection site erythema and injection site swelling. On an unknown date, the outcome of the injection site erythema and injection site swelling were recovered/resolved. The reporter considered the injection site erythema and injection site swelling to be related to SHINGRIX. Additional information was reported as follows: The reporter was the patient herself. The reporter reported that, two weeks after the vaccination the events improved but till the time of reporting, the outline of the circle where it was swollen was still visible. This case was linked to case US2018105432, reported by the same reporter.
pt recvd vax & had raised welt like rash over entire body; itchy & puffy eyes; felt warm & dizzy; to MD; meds given; to MD again; dph & epi given;
Patient presented on 11/29/13 with a local reaction: red, swollen, heated area. Patient referred to ER for check - Patient is opting to wait a few days before seeking treatment.
After injection patients arm was sore, patient applied tiger balm to help with soreness helped with soreness but then arm started to get red and itchy has now gone away.
red flat rash that was not a raised like a bee sting; rash over the back of the neck and over the right ear; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a physician.  This case involves a four months old patient who experienced red flat rash that was not a raised like a bee sting rash over the back of the neck and over the right ear (rash erythematous and rash), while he/she received vaccines DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL], HEPATITIS B VACCINE and PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) [PREVNAR].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received first set of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot number not reported via unknown route in the right thigh.  On an unknown date, the patient received first set of suspect HEPATITIS B VACCINE and PREVNAR not produced by Sanofi Pasteur lot number not reported via unknown route in the in left thigh.  On an unknown date, the patient developed a non-serious red flat rash that was not a raised like a bee sting (rash erythematous) and rash over the back of the neck and over the right ear (rash) 15 minutes following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE, HEPATITIS B VACCINE and PREVNAR.  Other relevant tests not reported.  Final diagnosis was rash and rash erythematous.  It was not reported if the patient received a corrective treatment.  The outcome was unknown for the events.  Information on the batch number was requested.  List of documents held by sender: none.
Within the first week of the shot, I developed a swollen knot in the right-side of my neck right above my collarbone. The knot is painful and when lightly touched, will move around freely. At times I feel lethargic; however, the knot has become the most uncomfortable.